Kronos Bio Operating Income

Kronos Bio (KRON) currently reports a operating income of $-70M as of March 2025. That compares with $-110M in the prior-year period — up 37.5% year over year. Use the charts on this page to explore Kronos Bio's operating income history and peer comparisons.

Kronos Bio's operating income increased from $-110M to $-70M — a 37.5% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Kronos Bio reported $-70M in operating income as of March 2025. That compares with $-110M in the prior-year period — up 37.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-70M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kronos Bio, and consider following KRON for alerts when major investors trade the stock.

Kronos Bio is classified in the Healthcare sector. On operating income, it currently shows $-70M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KRON with unrelated industries.